Lilly shareholders to vote again on splitting CEO, board chair roles
For the third year in a row, an investor is proposing that the pharmaceutical company scrap the tradition of combining the role of chief executive officer and board chair.
Pharmaceutical
Articles
Doctors finding hurdles to using pills to treat COVID-19
The goal is to get patients started on either Pfizer’s Paxlovid tablets or Merck’s molnupiravir capsules within five days of symptoms appearing. But the tight deadline has highlighted several challenges.
Moderna seeks FDA authorization for 4th dose of COVID shot
The company said its request for approval for all adults was made “to provide flexibility” to the Centers for Disease Control and Prevention and medical providers to determine the “appropriate use” of a second booster dose of the vaccine.
Eli Lilly cuts exports of ‘non-essential’ drugs to Russia
Additionally, the pharmaceutical giant said in a statement that it had “suspended all investments, promotional activities, and new clinical trials in Russia.”
Limits on insulin costs revived in push for Senate action
Nearly 30 million Americans have diabetes, and more than 6 million use insulin to keep their blood sugars under control. It’s an old drug, refined over the years, that has seen relentless price increases.
Purdue Pharma, U.S. states agree to new opioid settlement
In all, the plan could be worth more than $10 billion over time. It calls for members of the Sackler family to give up control of the Stamford, Connecticut-based company so it can be turned into a new entity with profits used to fight the crisis.
Pfizer nearing big gains in COVID treatment production
Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: Supplies were limited, and it would take months to make the tablets.
J&J, distributors finalize $26B landmark opioid settlement
Indiana stands to collect up to $507 million from the deal if communities opt into the state’s settlement under pending legislation in the Indiana General Assembly, according to the state attorney general’s office.
Lilly plans $700M genetic medicine institute in Boston
The Indianapolis-based pharmaceutical company said the facility is part of its strategy to advance RNA-based therapeutics and builds on its acquisition of Prevail Therapeutics, a gene therapy company based in New York.
FDA gives early-use authorization to Lilly’s new COVID-19 antibody
The Indianapolis-based drugmaker said the antibody is effective against the omicron variant and it has already manufactured several hundred thousand doses. The deal calls for the federal government to pay Lilly more than $720 million.
Pfizer’s COVID-19 vaccine for children under 5 faces delay
U.S. regulators on Friday put the brakes on their push to speed Pfizer’s COVID-19 to children under 5, creating major uncertainty about how soon the shots could become available.
Eli Lilly’s Alzheimer’s drug hits roadblock
The FDA has agreed to speed up review of donanemab, but the Centers for Medicare and Medicaid Services is moving to limit reimbursement for drugs in this class to only patients in clinical trials.
Lilly to supply 600K doses of new COVID-19 antibody to U.S., if OK’d by FDA
The deal calls for the federal government to pay Eli Lilly and Co. more than $720 million for the antibody, which the company said is effective against all COVID-19 variants.
Biden puts focus on drug prices as he tries to revive agenda
Efforts to lower prescription drug costs have long been popular with voters, but bipartisan consensus has proved elusive. It’s unclear if there’s a political path forward for Biden’s plans in Congress.
Lilly seeking FDA approval for new antibody it says works against omicron
In December, the U.S. government paused distribution of Lilly’s two previous antibodies, saying they did not appear effective against the omicron variant.
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5
If regulators agree to the long-awaited move, Pfizer shots containing just one-tenth of the dose given to adults could be dispensed to children as young as 6 months.
Mediator: Purdue Pharma close to reaching new settlement
A judge said in a court filing Monday that members of the Sackler family would contribute a “substantial additional consideration” above the $4.5 billion in cash and charitable assets they’ve already agreed to pay as part of a deal.
Michigan AG seeks to investigate Eli Lilly for high insulin prices
Indianapolis-based Eli Lilly and Co., one of three primary U.S. insulin manufacturers, said it was “deeply disappointed by the false accusations and inaccurate claims” made by the attorney general.
Pfizer begins testing omicron-matched COVID shots in adults
The new U.S. study will include up to 1,420 volunteers ages 18 to 55 to test the updated omicron-based shots for use as a booster or for primary vaccinations.
FDA expected to sharply restrict use of monoclonal antibodies made by Lilly, Regeneron
The Food and Drug Administration is poised as soon as Monday to restrict two monoclonal antibodies, saying the COVID-19 treatments should not be employed in any states because they are ineffective against the dominant omicron variant, according to two senior administration health officials.